Effect of a treatment for upper limb and language in post-stroke patients

Not Applicable

Recruiting

• Conditions: Aphasia; Hemiplegia; I64.0

• Registration Number: RBR-8q65vps
• Lead Sponsor: niversidade Federal de Sergipe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-31
• Study Completion: 2022-12-18
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients aged between 30 and 80 years will be included; of both sexes, diagnosis of ischemic or hemorrhagic stroke confirmed by computed tomography or magnetic resonance imaging, absence of cognitive deficits (assessed by the MMSE - Mini Mental State Examination, score greater than 18 ; All degrees of motor impairment according to the classification Fugl-Meyer score (total score 0 to 66 points): severe (Fugl-Meyer score 0 to 15 points), severe or moderate (16 to 34 Fugl-Meyer points), moderate/mild (35-53 Fugl points -Meyer) and mild (54 to 66 Fugl Meyer points); Aphasic patients will be evaluated by the Boston Naming Test and Montreal-Toulouse Battery Test (MTL-Brazil), in all degrees of impairment: alert for neuropsychological deficit (- 1.0 and -1.5), moderate to severe deficit (-1.6 and -2.0), presence of very severe deficit (less than or equal to -2.0), does not suggest cognitive deficit (greater than - 1.0)

Exclusion Criteria

Patients who present the following conditions will be excluded: clinical evidence of multiple brain lesions or other associated neurological diseases; peripheral neuropathies, leprosy, fibromyalgia, rheumatoid arthritis; other upper and lower motor neuron pathologies; history of psychiatric illness including drug and alcohol abuse; orthopedic deformities installed in the upper limbs. Those who are undergoing rehabilitation treatment during the collection (Occupational Physiotherapy and/or Speech Therapy) will not participate in the research. Patients with receptive types of aphasia (assessed by the MTL-Brazil test) will also be excluded. In addition to these, due to contraindication for the application of tDCS, patients with intracranial metallic implants will be excluded; pregnancy; use of medication that interferes with cortical excitability; history of seizures and/or epilepsy.

Study & Design

• Study Type: Intervention
• Study Design: Not specified